Literature DB >> 23548926

Cancer stem cells: the challenges ahead.

Jan Paul Medema1.   

Abstract

Cancer stem cells (CSCs) have been proposed as the driving force of tumorigenesis and the seeds of metastases. However, their existence and role remain a topic of intense debate. Recently, the identification of CSCs in endogenously developing mouse tumours has provided further support for this concept. Here I discuss the challenges in identifying CSCs, their dependency on a supportive niche and their role in metastasis, and propose that stemness is a flexible — rather than fixed — quality of tumour cells that can be lost and gained.

Entities:  

Mesh:

Year:  2013        PMID: 23548926     DOI: 10.1038/ncb2717

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  81 in total

1.  CD133+ niches and single cells in glioblastoma have different phenotypes.

Authors:  Karina Christensen; Henrik Daa Schrøder; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2010-12-24       Impact factor: 4.130

2.  Detection and characterization of putative metastatic precursor cells in cancer patients.

Authors:  Catherine Alix-Panabières; Jean-Pierre Vendrell; Olivier Pellé; Xavier Rebillard; Sabine Riethdorf; Volkmar Müller; Michel Fabbro; Klaus Pantel
Journal:  Clin Chem       Date:  2007-03       Impact factor: 8.327

Review 3.  Prostate cancer stem cell therapy: hype or hope?

Authors:  J R Masters; C Kane; H Yamamoto; A Ahmed
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-04-22       Impact factor: 5.554

Review 4.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 5.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

6.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

7.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

8.  Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

Authors:  Enza Lonardo; Patrick C Hermann; Maria-Theresa Mueller; Stephan Huber; Anamaria Balic; Irene Miranda-Lorenzo; Sladjana Zagorac; Sonia Alcala; Iker Rodriguez-Arabaolaza; Juan Carlos Ramirez; Raul Torres-Ruíz; Elena Garcia; Manuel Hidalgo; David Álvaro Cebrián; Rainer Heuchel; Matthias Löhr; Frank Berger; Peter Bartenstein; Alexandra Aicher; Christopher Heeschen
Journal:  Cell Stem Cell       Date:  2011-11-04       Impact factor: 24.633

Review 9.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  324 in total

1.  Bruceantin inhibits multiple myeloma cancer stem cell proliferation.

Authors:  Mark E Issa; Sarah Berndt; Gilles Carpentier; John M Pezzuto; Muriel Cuendet
Journal:  Cancer Biol Ther       Date:  2016-07-19       Impact factor: 4.742

2.  Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.

Authors:  S Colak; C D Zimberlin; E Fessler; L Hogdal; P R Prasetyanti; C M Grandela; A Letai; J P Medema
Journal:  Cell Death Differ       Date:  2014-03-28       Impact factor: 15.828

Review 3.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

4.  Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.

Authors:  Kristiaan J Lenos; Louis Vermeulen
Journal:  Ann Transl Med       Date:  2016-12

5.  Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.

Authors:  Yanru Wang; Jennifer A Freedman; Hongliang Liu; Patricia G Moorman; Terry Hyslop; Daniel J George; Norman H Lee; Steven R Patierno; Qingyi Wei
Journal:  Int J Cancer       Date:  2017-06-01       Impact factor: 7.396

Review 6.  Intestinal stem cells and the colorectal cancer microenvironment.

Authors:  Bryan A Ong; Kenneth J Vega; Courtney W Houchen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects.

Authors:  Yan Zhou; Jiyuan Yang; Johng S Rhim; Jindřich Kopeček
Journal:  J Control Release       Date:  2013-09-14       Impact factor: 9.776

8.  Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon cancer stem cells.

Authors:  S Colak; J P Medema
Journal:  Cell Cycle       Date:  2016-06-17       Impact factor: 4.534

9.  Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells.

Authors:  Simone Gaedicke; Friederike Braun; Shruthi Prasad; Marcia Machein; Elke Firat; Michael Hettich; Ravindra Gudihal; Xuekai Zhu; Kerstin Klingner; Julia Schüler; Christel C Herold-Mende; Anca-Ligia Grosu; Martin Behe; Wolfgang Weber; Helmut Mäcke; Gabriele Niedermann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

10.  High expression of OCT4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia.

Authors:  Jia-Yu Yin; Qin Tang; Ling-Ling Zhai; Ling-Yu Zhou; Jun Qian; Jiang Lin; Xiang-Mei Wen; Jing-Dong Zhou; Ying-Ying Zhang; Xiao-Wen Zhu; Zhao-Qun Deng
Journal:  Tumour Biol       Date:  2015-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.